Literature DB >> 20529827

The expression of GST isoenzymes and p53 in non-small cell lung cancer.

Serpil Oguztüzun1, Mehtap Aydin, Funda Demirag, Ulkü Yazici, Müzeyyen Ozhavzali, Murat Kiliç, Mesude Işcan.   

Abstract

This study investigated the immunohistochemical staining characteristics of glutathione-S-transferase alpha, pi, mu, theta and p53 in non-small cell lung carcinoma and normal lung tissue from 50 patients. The relationships between expressions of the Glutathione-S-transferase isoenzymes and some clinicopathological features were also examined. Expression of glutathione-S-transferase pi, mu, alpha, theta and p53 was assessed by immunohistochemistry for primary lung carcinomas of 50 patients from the Sanitarium Education and Research Hospital, Ankara lung cancer collection. The relationships between expression of the glutathione-S-transferase isoenzymes, p53 in normal and tumor tissue by Student T test and the clinicopathological data were also examined by Spearman Rank tests. When the normal and tumor tissue of these cases were compared according to their staining intensity and percentage of positive staining, glutathione-S-transferase alpha, pi, mu, theta expressions in tumor cells was significantly higher than normal cells (p<0.05). There was no significant difference in the expression of p53 between normal and tumor cells (p>0.05). When the immunohistochemical results of glutathione-S-transferase isoenzymes and p53 were correlated with the clinical parameters, there were no significant associations between glutathione-S-transferases and p53 expressions and tumor stage, tumor grade and smoking status (p>0.05).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20529827     DOI: 10.2478/v10042-008-0084-6

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  6 in total

1.  Correlation between metabolic enzyme GSTP1 polymorphisms and susceptibility to lung cancer.

Authors:  Yufei Wang; B U Ren; Lei Zhang; Zhanlin Guo
Journal:  Exp Ther Med       Date:  2015-07-30       Impact factor: 2.447

2.  Genetic polymorphisms in oxidative stress-related genes are associated with clinical outcome in patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitors.

Authors:  Yunhua Xu; Qunxiong Pan; Chongren Wang; Chunya He; Zijian Su; Xiaowei Guo; Jian Zhang; Min Kong; Shaoying Ke; Jianhua Zhang; Baofu Chen; Haihui Sheng; Xuelin Zhang
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

3.  Chemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer Cells.

Authors:  Marike W van Gisbergen; Marcus Cebula; Jie Zhang; Astrid Ottosson-Wadlund; Ludwig Dubois; Philippe Lambin; Kenneth D Tew; Danyelle M Townsend; Guido R M M Haenen; Marie-José Drittij-Reijnders; Hisao Saneyoshi; Mika Araki; Yuko Shishido; Yoshihiro Ito; Elias S J Arnér; Hiroshi Abe; Ralf Morgenstern; Katarina Johansson
Journal:  Mol Pharm       Date:  2016-04-28       Impact factor: 4.939

4.  Polymorphisms and Protein Expressions of Glutathione S-Transferase M1 and T1 in Non-Small Cell Lung Cancer.

Authors:  Murat Kiliç; Ahmet Oğuz Ada; Serpil Oğuztüzün; Funda Demirağ; Sezgin Çelik; Pınar Biçakçioğlu; Mümtaz Işcan
Journal:  Turk J Pharm Sci       Date:  2017-11-20

5.  Effects of zerumbone on proliferation and apoptosis of esophageal cancer cells and on P53 and Bcl-2 expression levels.

Authors:  Shiyang Ma; Yali Lei; Li Zhang; Jinhai Wang
Journal:  Oncol Lett       Date:  2018-07-20       Impact factor: 2.967

6.  Quinacrine inhibits GSTA1 activity and induces apoptosis through G1/S arrest and generation of ROS in human non-small cell lung cancer cell lines.

Authors:  Makhan Kumar; Ansie Martin; Snehal Nirgude; Bibha Chaudhary; Sukanta Mondal; Angshuman Sarkar
Journal:  Oncotarget       Date:  2020-05-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.